Skip to main navigation Skip to search Skip to main content

Acute-phase reactants as predictors of chronic kidney disease incidence in Africans: the population-based prospective RODAM cohort study

  • Muhulo M. Mungamba
  • , Felix P. Chilunga
  • , Eva L. Van Der Linden
  • , Erik Buene
  • , Charles F. Hayfron-Benjamin
  • , Karlijn A.C. Meeks
  • , Samuel N. Darko
  • , Ellis Owusu-Dabo
  • , Liffert Vogt
  • , Bert Jan Van Den Born
  • , Benedicta N. Nkeh-Chungag
  • , Charles Agyemang
  • Amsterdam Public Health
  • Walter Sisulu University
  • Amsterdam UMC
  • National Human Genome Research Institute (NHGRI)
  • University of Maryland School of Medicine
  • Kwame Nkrumah University of Science and Technology
  • University of Amsterdam
  • Johns Hopkins University School of Medicine

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Chronic kidney disease (CKD) and chronic inflammation are highly prevalent in African populations, yet their relationship remains understudied. We examined the association between acute-phase reactants (C-reactive protein and ferritin) as markers of acute and chronic inflammation and the incidence of CKD 6 years later in a prospective Ghanaian population-based cohort. Methods: Data from the prospective Research on Obesity and Diabetes among African Migrants (RODAM-Pros) cohort were analysed and included participants living in rural and urban Ghana and Ghanaian migrants in the Netherlands. Acute-phase reactants were assessed between 2012 and 2015, while CKD incidence was assessed between 2019 and 2021 by using the race-free Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) 2021 equation. Robust Poisson regression models adjusted for potential confounders were used to assess associations. We explored interactions with age, sex, education, and geographical location, and stratified C-reactive protein (CRP) analyses by using established clinical cutoffs. The role of ferritin as an iron-storage marker was also evaluated. Results: Among 1435 participants, the baseline CRP was not associated with CKD incidence at follow-up [adjusted incidence rate ratio (aIRR) 1.02; 95% confidence interval (CI): 0.84–1.15]. Higher ferritin levels were associated with increased CKD risk (aIRR 3.53; 95% CI: 2.42–5.01) and albuminuria (aIRR 4.22; 95% CI: 2.87–6.10), but not with reduced estimated glomerular filtration rate (aIRR 0.99; 95% CI: 0.92–1.05). No effect modification was observed by age, sex, education, or geographical location. We found no evidence that iron overload or deficiency contributed to the ferritin–CKD relationship. Conclusion: Elevated ferritin levels, but not CRP levels, were associated with future CKD risk in Ghanaians. Multi-population prospective studies with repeated ferritin measurements are needed to better understand the links between ferritin, iron status, and CKD in African populations.

Original languageEnglish
JournalInternational Journal of Epidemiology
Volume55
Issue number3
DOIs
Publication statusPublished - Jun 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • C-reactive protein
  • chronic inflammation
  • chronic kidney disease
  • ferritin
  • inflammatory markers
  • iron overload
  • sub-Saharan Africa

Fingerprint

Dive into the research topics of 'Acute-phase reactants as predictors of chronic kidney disease incidence in Africans: the population-based prospective RODAM cohort study'. Together they form a unique fingerprint.

Cite this